Shares of Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) have been given an average rating of “Hold” by the five analysts that are presently covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $29.40.
Several analysts have issued reports on TRUP shares. Canaccord Genuity Group cut their price objective on Trupanion from $40.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday. Evercore ISI dropped their price target on Trupanion from $35.00 to $31.00 and set an “outperform” rating on the stock in a research report on Tuesday, February 20th. Stifel Nicolaus raised their price objective on Trupanion from $25.00 to $28.00 and gave the stock a “hold” rating in a research note on Friday, February 16th. Finally, Piper Sandler lowered their target price on shares of Trupanion from $28.00 to $22.00 and set a “neutral” rating for the company in a research note on Friday.
Read Our Latest Report on TRUP
Institutional Investors Weigh In On Trupanion
Trupanion Stock Performance
Shares of TRUP opened at $19.85 on Friday. Trupanion has a 52-week low of $18.45 and a 52-week high of $36.82. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.42. The firm has a market cap of $833.50 million, a price-to-earnings ratio of -31.02 and a beta of 1.76. The business’s 50 day moving average is $25.61 and its two-hundred day moving average is $26.72.
Trupanion (NASDAQ:TRUP – Get Free Report) last announced its quarterly earnings data on Thursday, May 2nd. The financial services provider reported ($0.16) earnings per share for the quarter, topping the consensus estimate of ($0.18) by $0.02. The company had revenue of $306.12 million during the quarter, compared to analyst estimates of $300.51 million. Trupanion had a negative net margin of 2.31% and a negative return on equity of 9.10%. The firm’s revenue for the quarter was up 19.4% compared to the same quarter last year. During the same period last year, the business earned ($0.60) EPS. Analysts forecast that Trupanion will post -0.43 EPS for the current fiscal year.
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
See Also
- Five stocks we like better than Trupanion
- What is a Low P/E Ratio and What Does it Tell Investors?
- MarketBeat Week in Review – 4/29 – 5/3
- How to Use the MarketBeat Dividend Calculator
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- What Does a Stock Split Mean?
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.